openPR Logo
Press release

SMi’s 6th annual Biomarkers Summit 2013 - Innovations in stratified medicine

09-18-2012 10:44 PM CET | Health & Medicine

Press release from: SMi Group

SMi’s 6th annual Biomarkers Summit 2013 - Innovations

The drive towards personalized medicine is seeing pharma move from patient stratification as a ‘nice to have’, to an essential feature of product development. Exemplified by the success of Herceptin, biomarkers promise to transform drug discovery, clinical development and diagnostics in the R&D process. This dynamic market, poised to reach a value of $33.3 billion by 2015, will continue to improve decision-making, clinical trial success rates and translational productivity.

Drawing on advances in genomics, translational medicine and clinical trial design, SMi’s sixth annual Biomarkers Summit held on 16th &17th January 2013 London brings you the latest developments from toxicity testing to compound screening and first-in-man studies to companion diagnostic assays, stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical development. Attending will enable you to:

• Accelerate companion diagnostics development for therapeutic indications

• Validate and deliver biomarkers for patient selection during clinical trials

• Implement sub-grouping in patient segmentation studies

• Utilise revised FDA regulatory guidelines to aid product development

• Optimise reimbursement strategies for diagnostics

• Maximise biomarker identification using epigenetic and metabolomic insights

For more information visit http://www.smi-online.co.uk/goto/biomarkers-summit17.asp alternatively contact Farhaana Rahman on +44 0 207 827 6186 or email on frahman@smi-online.co.uk

The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk

SMi Group Ltd
2nd Floor South, Harling House
47-51 Great Suffolk Street,
London, SE1 0BS

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi’s 6th annual Biomarkers Summit 2013 - Innovations in stratified medicine here

News-ID: 236583 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for SMi’s

SMi’s 3D Cell Culture conference 2022 – Speakers announced
SMi Reports: Agenda and speaker overview of the upcoming 5th Annual 3D Cell Culture Conference. SMi Group is delighted to announce the return of the successful 3D Cell Culture Conference for its 5th year, taking place on 9th and 10th February 2022 in London, UK. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in
10-14-2019 | Health & Medicine
SMI
SMi’s 3D Cell Culture conference 2020 – Speakers announced
SMi Reports: Agenda and speaker overview of the upcoming 4th Annual 3D Cell Culture Conference 2020, in London SMi Group is delighted to announce the return of the successful 3D Cell Culture Conference for its 4th year, taking place on 19th and 20th February 2020 in London. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for
SMi’s Lyophilisation 2019 Conference: Interview with Geoff Smith
Geoff Smith from De Montford University will be speaking at SMi’s 7th Annual Lyophilisation Conference which will take place in London on 3rd – 4th June 2019. He will be speaking on the applications for impedance spectroscopy in the determination of in-vial phase behaviour. Ahead of the conference, SMi interviewed Geoff where he gave a taster on what he will be discussing. Geoff Smith: “The first technology we developed was
Registration opens for SMi’s leading Pain Therapeutics Conference
SMi Group is proud to announce the 19th Annual Pain Therapeutics Conference is taking place at the Copthorne Tara Hotel in London, UK on the 13th and 14th May 2019. The global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, post-surgical
Final Reminder: 1 Week Until SMi’s Lyophilization USA
With the event now just 1 week away, I wanted to remind you that there is still time to secure your place at SMi's 4th annual event, Lyophilization USA, taking place on November 15th and 16th in Iselin, New Jersey. Are you looking to find out about novel techniques and advances within Lyophilization? Regulatory and freeze-drying challenges? Beyond vial Lyophilization: alternatives to conventional methods than you need to attend and gain
SMi’s Defence Logistics (CEE) – New Speakers & Updates
Join the world's leading military logisticians at Defence Logistics Central and Eastern Europe in Prague this March, to hear updates on enhancing multinational logistics collaboration for regional collective defence. This highly anticipated two-day event will focus specifically on regional logistics operations, joint interoperability, and strategy optimisation, covering a blend of: transport, supply chain and MRO management, medical logistic operations, lifecycle management, C2, and much more. www.defence-logistics.eu/opr SMi are delighted to welcome